A collaborative effort by the Formosa-Jordan lab from the Max Planck Institute for Plant Breeding Research in Cologne, ...
Measuring the lymphocytes—white blood cells that fight infection—in a patient's blood can be used to predict outcomes in ...
Microtubules perform an active role in communication within the cell by transmitting received signals to the cell's ...
SINGAPORE,First and only chemotherapy-free combination in the first-line setting to demonstrate an overall survival benefit versus osimertinib among Asian patients.
New three-year follow-up results from the TRANSCEND FL trial show that patients with relapsed or refractory follicular ...
A study published in the NEJM looks at universal base-edited CAR7 T cells for T-cell acute lymphoblastic leukemia. Dr Tania Dexter, senior medical officer at UK stem cell charity Anthony Nolan, said: ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new data highlighting the potential of ...
Gilead Sciences' Kite unit has showcased three new CAR-T therapies at ASH, headed by multiple myeloma candidate ...
French business jet developer Beyond Aero has kicked off the hunt for a location for its future production centre, having ...
Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemiasFindings underscore ...
Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an objective response rate ...
Bristol Myers Squibb (NYSE: BMY) reinforces its hematology leadership through new research across multiple therapies for patients with lymphoma at the 67th American Society of Hematology (ASH) Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback